The results of our analysis show that high levels of expression of CLRs are significantly associated with higher levels of dendritic cell infiltration, which suggests that CLRs in bladder cancer may also participate in the regulation of immune response by modulating dendritic cell differentiation and function. The gene discussed is LARS1; the disease is urinary bladder carcinoma.